Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating high-dose sequential therapy followed by a single autologous stem cell transplant in multiple myeloma. The…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma [Phase 2]
Phase 2 trial investigating bortezomib and bendamustine for relapsed/refractory multiple myeloma; study terminated with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy [Phase 3]
This is a Phase 3 clinical trial update involving patients with multiple myeloma and renal failure due to myeloma cast nephropathy. The stud…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: FREE Study - Fracture Reduction Evaluation [Phase 4]
Phase 4 trial update on Medtronic Spine's FREE study evaluating fracture reduction in osteopenia and osteoporosis; the study also includes p…
-
FDA approval · 2017-12-08FDA Approved: MELPHALAN HYDROCHLORIDE — Original Application (Dr.Reddy's Laboratories Inc)
FDA approves Dr. Reddy's Laboratories' Melphalan hydrochloride as an original generic application.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-12-06Clinical Trial Update: Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) [Phase 1, Phase 2]
Phase 1/2 study investigating Antiminor Histocompatibility Complex (MiHA) T cells in patients with relapsed hematologic malignancies after m…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Total Marrow Irradiation for Refractory Acute Leukemia [Phase 1]
A Phase 1 trial evaluating total marrow irradiation for refractory acute leukemia has completed enrollment/status; the study included patien…
-
CLINICAL_TRIALS research · 2017-12-04Clinical Trial Update: A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea
A completed post-approval study in Korea collecting safety and efficacy data for multiple myeloma patients treated with REVLIMID (lenalidomi…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases [Phase 1]
Phase 1 trial evaluating the safety of Umbilical Cord Blood T-Regulatory Cell infusion followed by donor cord blood transplant in patients w…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating infusion of regulatory T cells after umbilical cord blood transplant in patients with advanced hematologic…
-
FDA approval · 2017-12-01FDA Approved: MOZOBIL — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Mozobil (plerixafor) filed by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2017-11-30FDA Approved: POMALYST — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for POMALYST (pomalidomide) submitted by Celgene Corporation.
-
FDA approval · 2017-11-30FDA Approved: THALOMID — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for THALOMID (thalidomide) submitted by Celgene Corporation.
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma [Phase 3]
A Phase 3 trial comparing maintenance therapy with lenalidomide and dexamethasone versus lenalidomide, dexamethasone plus ixazomib after aut…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating dalteparin, lenalidomide, and low-dose dexamethasone in previously untreated multiple myeloma was terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial update on using combination chemotherapy and total-body irradiation before donor umbilical cord blood transplant in patien…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating filgrastim compared with sargramostim plus chemotherapy, peripheral stem cell transplantation, and interferon alf…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating donor T cells in high-risk hematologic cancers undergoing donor peripheral blood stem cell transplant was termina…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant [Phase 1]
A Phase 1 trial assessing CpG 7909 in patients who have undergone autologous stem cell transplant has been terminated. The study included pa…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [NA]
ClinicalTrials.gov entry describes termination of a study evaluating donor umbilical cord blood transplantation for various hematologic canc…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Sequential High-dose Dexamethasone and Response Adopted PAD or VAD Induction Chemotherapy Followed by High-dose Chemotherapy With Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma [Phase 2]
A Phase 2 trial tested sequential high-dose dexamethasone followed by PAD or VAD induction chemotherapy and then high-dose chemotherapy with…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma [Phase 1]
Phase 1 study evaluating a triple combination of pomalidomide, marizomib, and low-dose dexamethasone in relapsed and refractory multiple mye…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma [Phase 1]
Phase 1 trial update of NPI-0052 (marizomib) and vorinostat in patients with non-small cell lung cancer, pancreatic cancer, melanoma, lympho…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers [Phase 2]
Phase 2 study of Vemurafenib in participants with BRAF V600 mutation–positive cancers, including multiple myeloma and other neoplasms; resul…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors [NA]
The document reports a completed University of North Carolina clinical trial studying survivorship and psychological outcomes in bone marrow…